Our Leadership Team

Dara Lockert
CEO

  • 25+ years experience in drug development with increasing staff leadership responsibility in biologics, gene therapy, immunotherapy, genomics, and vaccines companies

  • Coached C-Suite leaders in the development of strategic plans resulting in successful launches, IND filings, corporate partnering/out licensing, M&As, and funding rounds

  • Leadership responsibility for commercial product launches and multiple Phase 4 registries

BRIAN MILLER
CHIEF BUSINESS OFFICER

  • 25+ years experience in life sciences, initially at large pharma and most recently at multiple biotech companies as C-level executive

  • Experienced in entrepreneurship, strategy, fundraising, operations, and business and corporate development with over $2B in deal value generated 

  • Combines scientific background with business experience to lead diverse functional teams and translate technical innovation from concept to clinic

LORI HANSEN, PHD
director of product development consulting

  • 25+ years of program management experience in the biopharma industry

  • Breadth of experience includes small molecules, biologics, cellular products, vaccines, and antibody drug conjugates (ADCs)

  • Expertise in the transition of projects from research to development and development to commercial; program planning and implementation; and the valuation of internal and external projects for effective Portfolio Management and Business Development